Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019

SELL
$23.15 - $28.34 $463,000 - $566,800
-20,000 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$22.03 - $32.01 $881,200 - $1.28 Million
-40,000 Reduced 66.67%
20,000 $519,000
Q3 2018

Nov 13, 2018

SELL
$30.0 - $40.85 $804,000 - $1.09 Million
-26,800 Reduced 30.88%
60,000 $1.9 Million
Q2 2018

Aug 15, 2018

BUY
$26.4 - $42.0 $2.29 Million - $3.65 Million
86,800 New
86,800 $3.37 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $268M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Scp Investment, LP Portfolio

Follow Scp Investment, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scp Investment, LP, based on Form 13F filings with the SEC.

News

Stay updated on Scp Investment, LP with notifications on news.